TITLE

Needle or Patch?

AUTHOR(S)
Singh, Seema
PUB. DATE
May 2007
SOURCE
Red Herring;5/28/2007, Vol. 4 Issue 17/18, p30
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on efforts of companies to develop better drug delivery systems (DDS). Small biotech firms and generics companies are part of the effort to develop DDS. Morgan Stanley says it is the pharmaceutical industry's fastest-growing single segment and will reach $100 billion in annual sales in 2007. Japan's Fuji Chemical, for instance, just reported that it has initiated steps to get U.S. Food and Drug Administration approval for its F-Melt type C, an additive which helps tablets dissolve in under 30 seconds. In India, Dabur Pharma recently launched Nanoxel, a nano-particle drug delivery system for Paclitaxel, an anticancer drug which right now has to be mixed with cremophor, a toxic castor-oil derivative, to make it water soluble.
ACCESSION #
25393619

 

Related Articles

  • New drug delivery good for older drugs. Belden, Heidi // Drug Topics;4/17/2006, Vol. 150 Issue 8, p20 

    The article focuses on the innovative delivery of drugs approved by the United States Food and Drug Administration. Great strides have been made in the development of drug entities but an easier way for companies to maintain market share and compete with generics is to utilize newer delivery...

  • Tysabri given green light to return.  // Drug Topics;6/19/2006, Vol. 150 Issue 12, p6 

    The article reports that the U.S. Food and Drug Administration will allow natalizumab (Tysabri, Biogen Idec/Elan), the multiple sclerosis treatment, to return to the market under the TOUCH prescribing program. It will be prescribed, distributed, and infused only by prescribers, infusion centers,...

  • Mindray gets FDA nod for anesthesia delivery system.  // Diagnostics & Imaging Week;6/19/2008, Vol. 11 Issue 25, p12 

    The article reports on the clearance received by Shenzhen, China-based Mindray Medical International from the U.S. Food and Drug Administration (FDA) for its AS3000 next-generation anesthesia delivery system. The product was developed by Datascope Patient Monitoring. The system was designed to...

  • Cook gets IDE approval for trial of smallest AAA graft. Yoffee, Lynn // Medical Device Daily;11/24/2008, Vol. 12 Issue 229, p1 

    The article reports on the Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) received by Cook Medical for a trial of a radically smaller endograft delivery system that would make endovascular aortic repair (EVAR) available to more...

  • Trojan Microparticles for Drug Delivery. Anton, Nicolas; Jakhmola, Anshuman; Vandamme, Thierry F. // Pharmaceutics;Mar2012, Vol. 4 Issue 1, p1 

    During the last decade, the US Food and Drug Administration (FDA) have regulated a wide range of products, (foods, cosmetics, drugs, devices, veterinary, and tobacco) which may utilize micro and nanotechnology or contain nanomaterials. Nanotechnology allows scientists to create, explore, and...

  • FDA clears Power Wand IV catheter for reduced sticks. PEDERSEN, AMANDA // Medical Device Daily;3/30/2011, Vol. 15 Issue 61, p1 

    This article reports on the U.S. Food and Drug Administration 510(k) clearance received by Access Scientific for a device that it claims will reduce the number of needle sticks hospital patients have to endure. The Power Wand device is an extended-dwell, power-injectable intravenous catheter...

  • You're telling us…. Brekke, Alexis // Pharmaceutical Technology;Feb2008, Vol. 32 Issue 2, p14 

    The article reports on the creation of PharmTech Polls, a new feature at pharmtech.com. that offers a voice online and allows feedbacks on the important topics in the pharmaceutical industry. Feedbacks from readers include their definitions of "design space" forecasts for the future of...

  • Chance for change?  // Nature Reviews Drug Discovery;Jan2006, Vol. 5 Issue 1, p3 

    With the number of drug approvals plummeting, and fears that current drug safety issues are slowing the regulatory process, a fundamental reassessment of how drugs are brought to the market seems crucial. Given the ever-growing time and cost of clinical development, this area looks to be...

  • News Brief.  // American Journal of Health-System Pharmacy;11/1/2012, Vol. 69 Issue 21, p15 

    The article reports that the FDA has announced that pharmacies generally do not have to provide a medication guide when dispensing a drug to a health care professional.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics